Told Corp. closes three-for-one deal as large tenants expand
Camarillo-based Told Corp., one of the most prolific developers in the Tri-Counties, recently closed a three-way deal that added another industrial property to its portfolio and allowed it to retain two important tenants.
Read More →Amgen teams up with Merck on melanoma treatments
Thousand Oaks-based Amgen and pharmaceutical giant Merck are working together to evaluate the safety and effectiveness of combined treatments for melanoma patients.
Read More →ValueClick rebrands to Conversant
Online advertising firm ValueClick has changed its name to Conversant and recalibrated its business model to focus on helping marketers better target individual consumers.
Read More →Solar projects boom but some fear a bubble
Solar installers boomed in 2013 and are expecting another good year, but some are skeptical about the new financial models underlying the growth numbers.
Read More →Amgen profits hit $5B, beat expectations
The biotech company recorded earnings per share of $7.60, well above the $7.46 expected by a survey of 27 analysts by Thomson Reuters.
Read More →
Sponsored content:
2015-2016 Giving Guide
